EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution
Press Release €451M Revolving Credit Facility refinanced with a maturity extended to February 2029Issuance of a €200M Perpetual Deeply Subordinated…
Pharmaceuticals, Biotechnology and Life Sciences
Press Release €451M Revolving Credit Facility refinanced with a maturity extended to February 2029Issuance of a €200M Perpetual Deeply Subordinated…
Listing market: Euronext Paris (Market segment C – ISIN Code: FR001400K4B1- Symbol: PHXM) Website : www.phaxiam.com DateTotal of shares composing the…
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) — Guggenheim Securities, LLC is issuing a statement on behalf of former Pfizer…
Strategic Agreements Unite Companies to Enhance Operational Synergies in the California Cannabis MarketSALINAS, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) —…
LOS ANGELES, Oct. 09, 2024 (GLOBE NEWSWIRE) — Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced today…
RADNOR, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today…
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical…
WESTLAKE VILLAGE, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced…
HOUSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its…
Company announcement – No. 48 / 2024 Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism U.S. Food…